Robert Lorne Hopfner, Director at Vaxcyte, Inc. (PCVX), sold 106,995 shares at $25.61 ($2.7M) on 2021-01-25, disclosed to the SEC on 2021-01-27.
Open-market sale of $2.7M PCVX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.61 | 19,511 | $500K | 18.2% |
| 2 | $25.61 | 19,511 | $500K | 18.2% |
| 3 | $26.07 | 15,461 | $403K | 14.7% |
| 4 | $26.07 | 15,461 | $403K | 14.7% |
| 5 | $25.23 | 16,769 | $423K | 15.4% |
| 6 | $25.23 | 16,769 |
| $423K |
| 15.4% |
| 7 | $26.13 | 1,373 | $36K | 1.3% |
| 8 | $25.30 | 2,140 | $54K | 2.0% |
| Total | $25.62 avg | 106,995 | $2.7M | 100% |
| Filing → |
| INZY | BUY | 2023-05-15 | $5.7M | — | Filing → |
| INZY | BUY | 2023-03-30 | $3.1M | — | Filing → |
| INZY | BUY | 2023-03-29 | $1.7M | — | Filing → |